Prnewswire Biomedican News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prnewswire biomedican. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prnewswire Biomedican Today - Breaking & Trending Today

Biomedican Receives Approval Notification From the U.S. Patent Office on Its 1st Patent

Biomedican Receives Approval Notification From the U.S. Patent Office on Its 1st Patent
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Dennis Oneill , Prnewswire Biomedican , Maxim Mikheev , Yarrowia Lipolytica , Pitchia Pastoris , Olivetolic Acid , President Dennis , டென்னிஸ் ஓனேிழில் , ப்ரெஸிடெஂட் டென்னிஸ் ,

Biomedican Receives Approval Notification From the U.S. Patent Office on Its 1st Patent

Biomedican Receives Approval Notification From the U.S. Patent Office on Its 1st Patent
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Dennis Oneill , Prnewswire Biomedican , Maxim Mikheev , Yarrowia Lipolytica , Pitchia Pastoris , Olivetolic Acid , President Dennis , டென்னிஸ் ஓனேிழில் , ப்ரெஸிடெஂட் டென்னிஸ் ,

BioMedican Discovers New Class of Cannabinoids; Sesqui CBG

BioMedican Discovers New Class of Cannabinoids; Sesqui CBG
Breakthrough discovery of a new class of Cannabinoids - Sesqui CBG
News provided by
Share this article
Share this article
SAN FRANCISCO, Dec. 10, 2020 /PRNewswire/ BioMedican has discovered a patent-pending process to biosynthesize a new class of rare Cannabinoids called Sesqui-Cannabinoids. In this class of rare Cannabinoids, there is only one paper that describes the properties of Sesqui-CBG in 2011, but there are several articles that note the presence of Sesqui-CBGA or even Sesqui-CBDA in plants, but only in the list of detected compounds (no properties described). The company filed a patent last month, and BioMedican can now produce Sesqui-CBG. In the next six months, the company expects to be able to produce Sesqui-CBD, Sesqui-CBN, Sesqui-THCV, Sesqui-THCA. ....

United States , Dennis Oneill , Prnewswire Biomedican , Maxim Mikheev , Scientific Cannabis Therapeutics , Sesqui Cannabinoids , Biosynthesis Platform , Scientific Cannabinoids Therapeutics , Pharmaceutical Grade , ஒன்றுபட்டது மாநிலங்களில் , டென்னிஸ் ஓனேிழில் , அறிவியல் கஞ்சா சிகிச்சை , மருந்து தரம் ,